Aneuscreen

Decision-support System for the Early Detection of Brain Aneurysms

Health Tech & Life Sciences
Active
Seed Netanya Founded 2017
Website ↗
Total raised
$1.2M
Last: Seed 2020-08
Stage
Seed
Founded
2017
Headcount
5
HQ
Netanya
Sector
Health Tech & Life Sciences

About

Aneuscreen brings new insights into the pathogenesis of brain aneurysms. The company has developed a revolutionary "once in a lifetime" cost-effective, and highly accurate diagnostic exam, for predicting a future formation of cerebral aneurysms using advanced computer vision (AI) techniques. The solution also detects existing aneurysms at an early stage (less than 4mm), compensating for the fact that these small instances tend to be missed by radiologists, hence saving lives, while lowering the economic burden related to the severe outcomes resulting from a rupture event (Subarachnoid hemorrhage (SAH)).

The solution acts both as a decision support tool for aneurysm detection as well as a classifier for identifying individuals who are susceptible for aneurysm development, based on morphology analysis of the brain's arterial tree. The solution can be executed on top of any neuroimaging modality that contains vascular demonstration.

Funding history · 2 rounds · $1.2M total

2020-08
Seed $1.0M
2017-09
Pre-Seed $216K

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical Decision Support
Technologies
Artificial IntelligenceDeep LearningImage RecognitionComputer Vision
Target customers
Healthcare & Life SciencesHealthcareInsurance CompaniesProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

diagnosticspreventioncloud-basedmachine-visiondigital-healthcareartificial-intelligencehealth-insurancemachine-learninghealthcare-providersdecision-supporthealthcare-ithealthcarehospitalsearly-detectionbrain-disorder